Green light for cancer treatment

The European Commission (EC) has authorized the Trade Mark Implementation (MAA) for CAMCEVI® 42 mg protracted suspended for infusion, for the treatment of oestrogen advanced prostate cancer, as well as high-risk localized prostate and advanced or metastatic hormone-dependent prostate in combination with radiotherapy, according to Foresee Pharmaceuticals (6576.TWO). The...

Read more

Corona creeping up on Liechtenstein

Thirty more Liechtenstein residents came back positive again for corona virus within three days. According to the Ministry for Statistics, 14 new infections were discovered on Monday, 15 on Tuesday, and one on Wednesday. There’s no Covid 19 patient at the state hospital as of Wednesday evening. Over the last...

Read more